Beyfortus 50 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FT5HG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $62,468
Award facts
- Contract value 100% obligated
- $62,468.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $62,468.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Beyfortus 50 mg/0.5 ml syringes on January 12, 2026, with an ultimate completion date of January 13, 2026. This non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Beyfortus is a respiratory syncytial virus (RSV) monoclonal antibody immunoglobulin used for passive immunization, primarily in pediatric populations. AmerisourceBergen Drug Corp is the subsidiary operating entity of parent company Cencora, Inc., a major pharmaceutical distributor providing critical medical products to federal government healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses a broad range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and other critical healthcare materials for use across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The competitively awarded structure of this and related task orders demonstrates AmerisourceBergen's established capability to efficiently fulfill government pharmaceutical procurement requirements.
Quick answers
Who was awarded contract SPE2DR26FT5HG?
SPE2DR26FT5HG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FT5HG worth?
The government has obligated $62,468 on SPE2DR26FT5HG.
Is contract SPE2DR26FT5HG an order under another contract?
Yes. SPE2DR26FT5HG is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT5HG competed?
The extent of competition for SPE2DR26FT5HG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award